Regulation of the SM-20 prolyl hydroxylase gene in smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 317, Issue 3, 2004, Pages 801-810

  Menzies, Keon ^a   Liu, Bin ^a   Kim, William J H ^a   Moschella, Maria C ^a   Taubman, Mark B ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Differentiation; Fibroblasts; Gene regulation; Prolyl hydroxylase; Promoters; Sp1 Sp3; Transcription factors; Vascular smooth muscle

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

ANIMAL CELL; ARTERY INJURY; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYMATIC DEGRADATION; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; RAT; SMOOTH MUSCLE FIBER;

ANIMALS; BASE SEQUENCE; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; MUTATION; PROCOLLAGEN-PROLINE DIOXYGENASE; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY;

EID: 1842740162     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.115     Document Type: Article

References (37)

1. Wax S.D., Rosenfield C.L., Taubman M.B. Identification of a novel growth factor-responsive gene in vascular smooth muscle cells. J. Biol. Chem. 269:1994;13041-13047.
2. Taylor M.S. Characterization and comparative analysis of the EGLN gene family. Gene. 275:2001;125-132.
3. Aravind L., Koonin E.V. The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases. Genome Biol. 2:2001.
4. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., Ratcliffe P.J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 107:2001;43-54.
5. 2-regulated prolyl hydroxylation. Science. 292:2001;468-472.
6. Freeman R.S., Hasbani D.M., Lipscomb E.A., Straub J.A., Xie L. SM-20, EGL-9, and the EGLN family of hypoxia-inducible factor prolyl hydroxylases. Mol. Cells. 16:2003;1-12.
7. Madden S.L., Galella E.A., Riley D., Bertelsen A.H., Beaudry G.A. Induction of cell growth regulatory genes by p53. Cancer Res. 56:1996;5384-5390.
8. Lipscomb E.A., Sarmiere P.D., Crowder R.J., Freeman R.S. Expression of the SM-20 gene promotes death in nerve growth factor-dependent sympathetic neurons. J. Neurochem. 73:1999;429-432.
9. Lipscomb E.A., Sarmiere P.D., Freeman R.S. SM-20: a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. J. Biol. Chem. 1:2000;1.
10. Yin X.Y., Grove L.E., Prochownik E.V. Mmip-2/Rnf-17 enhances c-Myc function and regulates some target genes in common with glucocorticoid hormones. Oncogene. 20:2001;2908-2917.
11. Nesbit C.E., Tersak J.M., Grove L.E., Drzal A., Choi H., Prochownik E.V. Genetic dissection of c-myc apoptotic pathways. Oncogene. 19:2000;3200-3212.
12. Wolf G., Harendza S., Schroeder R., Wenzel U., Zahner G., Butzmann U., Freeman R.S., Stahl R.A. Angiotensin II's antiproliferative effects mediated through AT2-receptors depend on down-regulation of SM-20. Lab. Invest. 82:2002;1305-1317.
13. Moschella M.C., Menzies K., Tsao L., Lieb M.A., Kohtz J.D., Kohtz D.S., Taubman M.B. SM-20 is a novel growth factor-responsive gene regulated during skeletal muscle development and differentiation. Gene Expr. 8:1999;59-66.
14. Wax S.D., Tsao L., Lieb M.E., Fallon J.T., Taubman M.B. SM-20 is a novel 40-kDa protein whose expression in the arterial wall is restricted to smooth muscle. Lab. Invest. 74:1996;797-808.
15. 2+ mobilization and protein kinase C activation. J. Clin. Invest. 91:1993;547-552.
16. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:1991;2499.
17. Ausubel F.M., Katagiri F., Mindrinos M., Glazebrook J. Use of Arabidopsis thaliana defense-related mutants to dissect the plant response to pathogens. Proc. Natl. Acad. Sci. USA. 92:1995;4189-4196.
18. Chamley-Campbell J.H., Campbell G.R. What controls smooth muscle phenotype. Atherosclerosis. 40:1981;347-357.
19. Rao J., Zhang F., Donnelly R.J., Spector N.L., Studzinski G.P. Truncation of Sp1 transcription factor by myeloblastin in undifferentiated HL60 cells. J. Cell Physiol. 175:1998;121-128.
20. Chen F., Zhang F., Rao J., Studzinski G.P. Ectopic expression of truncated Sp1 transcription factor prolongs the S phase and reduces the growth rate. Anticancer Res. 20:2000;661-667.
21. Franz W.M., Mueller O.J., Fleischmann M., Babij P., Frey N., Mueller M., Besenfelder U., Moorman A.F., Brem G., Katus H.A. The 2.3. kb smooth muscle myosin heavy chain promoter directs gene expression into the vascular system of transgenic mice and rabbits Cardiovasc. Res. 43:1999;1040-1048.
22. Herring B.P., Smith A.F. Telokin expression is mediated by a smooth muscle cell-specific promoter. Am. J. Physiol. 270:1996;C1656-1665.
23. Li L., Miano J.M., Mercer B., Olson E.N. Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J. Cell Biol. 132:1996;849-859.
24. ′ and first intron promoter regions Circ. Res. 84:1999;852-861.
25. Madsen C.S., Regan C.P., Hungerford J.E., White S.L., Manabe I., Owens G.K. Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5'-flanking and first intronic DNA sequence. Circ. Res. 82:1998;908-917.
26. ′ -flanking region Biochem. Biophys. Res. Commun. 239:1997;598-605.
27. A.F. Smith, R.M. Bigsby, R.A. Word, B.P. Herring, A 310-bp minimal promoter mediates smooth muscle cell-specific expression of telokin, Am. J. Physiol. 274 (1998) C1188-C1195; discussion C1187.
28. Yet S.F., Folta S.C., Jain M.K., Hsieh C.M., Maemura K., Layne M.D., Zhang D., Marria P.B., Yoshizumi M., Chin M.T., Perrella M.A., Lee M.E. Molecular cloning, characterization, and promoter analysis of the mouse Crp2/SmLim gene. Preferential expression of its promoter in the vascular smooth muscle cells of transgenic mice. J. Biol. Chem. 273:1998;10530-10537.
29. Blank R.S., Thompson M.M., Owens G.K. Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells. J. Cell Biol. 107:1988;299-306.
30. Kindy M.S., Sonenshein G.E. Regulation of oncogene expression in cultured aortic smooth muscle cells. Post-transcriptional control of c-myc mRNA. J. Biol. Chem. 261:1986;12865-12868.
31. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:1995;487-517.
32. Black A.R., Black J.D., Azizkhan-Clifford J. Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell Physiol. 188:2001;143-160.
33. Philipsen S., Suske G. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 27:1999;2991-3000.
34. Vinals F., Fandos C., Santalucia T., Ferre J., Testar X., Palacin M., Zorzano A. Myogenesis and MyoD down-regulate Sp1. A mechanism for the repression of GLUT1 during muscle cell differentiation. J. Biol. Chem. 272:1997;12913-12921.
35. Santalucia T., Boheler K.R., Brand N.J., Sahye U., Fandos C., Vinals F., Ferre J., Testar X., Palacin M., Zorzano A. Factors involved in GLUT-1 glucose transporter gene transcription in cardiac muscle. J. Biol. Chem. 274:1999;17626-17634.
36. Maxwell P.H., Ratcliffe P.J. Oxygen sensors and angiogenesis. Cell Dev. Biol. 13:2002;29-37.
37. Suske G. The Sp-family of transcription factors. Gene. 238:1999;291-300.